Russell Investments Group’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.9M Sell
166,947
-18,528
-10% -$1.21M 0.01% 810
2025
Q1
$12.4M Buy
185,475
+44,979
+32% +$3.01M 0.02% 737
2024
Q4
$7.77M Sell
140,496
-17,462
-11% -$965K 0.01% 940
2024
Q3
$9.42M Buy
157,958
+54,953
+53% +$3.28M 0.01% 862
2024
Q2
$6.56M Sell
103,005
-3,670
-3% -$234K 0.01% 1017
2024
Q1
$7.37M Buy
106,675
+3,027
+3% +$209K 0.01% 978
2023
Q4
$5.72M Sell
103,648
-6,422
-6% -$354K 0.01% 1063
2023
Q3
$6.39M Sell
110,070
-10,724
-9% -$623K 0.01% 970
2023
Q2
$6.5M Buy
120,794
+45,709
+61% +$2.46M 0.01% 972
2023
Q1
$2.98M Sell
75,085
-9,574
-11% -$380K 0.01% 1347
2022
Q4
$3.41M Buy
84,659
+3,446
+4% +$139K 0.01% 1293
2022
Q3
$2.61M Sell
81,213
-7,335
-8% -$236K 0.01% 1404
2022
Q2
$2.63M Hold
88,548
0.01% 1438
2022
Q1
$2.49M Sell
88,548
-6,106
-6% -$171K ﹤0.01% 1526
2021
Q4
$4.36M Sell
94,654
-18,975
-17% -$874K 0.01% 1335
2021
Q3
$3.73M Sell
113,629
-8,770
-7% -$288K 0.01% 1425
2021
Q2
$4.29M Sell
122,399
-51,566
-30% -$1.81M 0.01% 1447
2021
Q1
$6.29M Sell
173,965
-59,114
-25% -$2.14M 0.01% 1224
2020
Q4
$6.77M Buy
233,079
+37,629
+19% +$1.09M 0.01% 1077
2020
Q3
$5.51M Buy
195,450
+95,321
+95% +$2.69M 0.01% 1077
2020
Q2
$3.22M Sell
100,129
-31,383
-24% -$1.01M 0.01% 1356
2020
Q1
$5.35M Buy
131,512
+16,310
+14% +$664K 0.01% 914
2019
Q4
$7.1M Buy
115,202
+18,760
+19% +$1.16M 0.01% 1013
2019
Q3
$7.03M Buy
+96,442
New +$7.03M 0.01% 1023
2019
Q1
Sell
-999
Closed -$45K 2907
2018
Q4
$45K Sell
999
-308
-24% -$13.9K ﹤0.01% 2807
2018
Q3
$74K Buy
1,307
+555
+74% +$31.4K ﹤0.01% 2792
2018
Q2
$50K Buy
+752
New +$50K ﹤0.01% 2805